PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers explore quantum entanglement

Paper in Physical Review Letters delves into phenomenon Einstein called 'spooky'

2013-02-08
(Press-News.org) Albert Einstein called quantum entanglement—two particles in different locations, even on other sides of the universe, influencing each other—"spooky action at a distance."

Einstein made the comment while criticizing quantum mechanics as incomplete—the phenomenon of quantum entanglement seems to be at odds with Einstein's theory of relativity.

"Eighty years after Einstein, quantum physics is still so mysterious that there are many different interpretations of its physical meaning. All the interpretations agree on what is going to be observed in any given experiment, but they each tell different stories of how these observations come about," says Christoph Simon with the Department of Physics and Astronomy in the Faculty of Science at the University of Calgary.

Simon and his colleague, Boris Braverman from the Massachusetts Institute of Technology have shown this spooky action at a distance in research published today in Physical Review Letters. The paper proposes a way in which the effect can be shown experimentally.

"We consider spooky action at a distance in the framework of an interpretation from the English physicist David Bohm who posited that every quantum particle has a well-defined position and velocity," says Simon.

"If the two particles are entangled, then performing an action on one has an immediate effect on the other and our paper shows how this effect can be demonstrated in an experiment with entangled photons."

Entangled photons present an exciting new method of secure communications—it's impossible for people to listen in. But this phenomenon can't be used for communication faster than the speed of light (what physicists call superluminal), allowing quantum physical systems to obey Einstein's theory of relativity, which posits that things can't communicate faster than light.

There is either no explanation for this—it's magic and somehow there are the same outcomes on each side—or the communication between photons is superluminal, which is problematic given the theory of relativity. "There has to be a way out," says Simon.

"Different pairs of particles coming from the same source have slightly different positions and velocities," he says. "If you observe just one of the two particles from a pair, you can't be sure if a variation in its velocity, say, is due to the long-distance influence of its partner, or whether it is just a statistical fluctuation. In this way the peaceful coexistence of quantum physics and relativity is preserved."

### END


ELSE PRESS RELEASES FROM THIS DATE:

A*STAR scientists' groundbreaking discovery of nucleus structure crucial to understanding diseases

A*STAR scientists groundbreaking discovery of nucleus structure crucial to understanding diseases
2013-02-08
1. Scientists from Singapore and Germany have identified that the proteins lamin A (Lmna) and lamin B receptor (Lbr) are essential for holding silent genes in their correct position at the edge of the nucleus, in the form of heterochromatin . A deviation from their normal position will cause the genes to malfunction, leading to heart failure, vascular disease and muscle wasting. 2. For hundreds of years before this discovery, scientists were puzzled by why heterochromatin clustered at the edge of the nucleus and how it was relevant to normal cell function. This recent ...

Rooting out recurrent breast cancer

2013-02-08
Due to chemotherapy resistance and a high rate of relapse, triple negative cancers are among the most difficult breast cancers to treat. In this issue of the Journal of Clinical Investigation, researchers led by Carlos Arteaga at Vanderbilt University identified a protein, TGF-β, that is highly expressed in triple negative breast cancer cells after chemotherapy. In a mouse model of breast cancer, TGF-β both diverted cells down a path to becoming cancerous and allowed for cancer to come back after treatment. Importantly, loss of TGF-β prevented tumor recurrence ...

New insight into RASopathy-associated lymphatic defects

2013-02-08
The RAS pathway is a cellular signaling pathway that regulates growth and development in humans. RASopathies are a group of diseases characterized by defects in RAS signaling. Many patients with RASopathies present with defects in the lymphatic system, which removes excess fluid from tissues, absorbs fats from the digestive system, and transports immune cells. To determine how alterations in the RAS pathway affect development of the lymphatic system, researchers at Yale University generated transgenic mice that expressed mutations associated with a RASopathy known as Noonan ...

Targeting T cells in rheumatoid arthritis

2013-02-08
Rheumatoid arthritis (RA) is an autoimmune disorder in which immune cells attack the joints, causing inflammation, swelling, and erosion. Specific sets of immune cells, known as T cells, are responsible for inducing disease. In this issue of the Journal of Clinical Investigation, researchers led by Harvey Cantor at Harvard University analyzed the contributions of different subsets of T cells to an RA-like condition in mice. Cantor and colleagues identified a subset of regulatory T cells (CD8+ Tregs) that can remove pathogenic T cell subsets and inhibit disease progression. ...

JCI early table of contents for Feb. 8, 2013

2013-02-08
Rooting out recurrent breast cancer Due to chemotherapy resistance and a high rate of relapse, triple negative cancers are among the most difficult breast cancers to treat. In this issue of the Journal of Clinical Investigation, researchers led by Carlos Arteaga at Vanderbilt University identified a protein, TGF-β, that is highly expressed in triple negative breast cancer cells after chemotherapy. In a mouse model of breast cancer, TGF-β both diverted cells down a path to becoming cancerous and allowed for cancer to come back after treatment. Importantly, loss ...

Comparing mechanical clot removal and standard medical therapy for severe stroke

2013-02-08
WASHINGTON – Results of the first randomized controlled study to evaluate a procedure that removes blood clots in the brain from patients experiencing severe strokes will be presented at the International Stroke Conference in Honolulu, Hawaii on Feb. 8. The study also evaluates if imaging techniques were helpful in identifying patients who potentially would benefit most from clot removal. In addition to the presentation, the full study, led by Chelsea Kidwell, M.D., professor of neurology and director of the Stroke Center at Georgetown University Medical Center, will ...

Yeast we can! New report answers questions on microbiology and beer

2013-02-08
WASHINGTON, DC – February 5, 2013 – What do microbes have to do with beer? Everything! Because the master ingredient in beer is yeast – a microbe – and every step in the brewing process helps the yeast do its job better. A new freely-available report; FAQ: If the Yeast Ain't Happy, Ain't Nobody Happy: The Microbiology of Beer explores the synergy between microbiology and brewing beer. "Every time someone brews a batch of beer, in a very real sense he or she is doing a microbiology experiment. If you brew beer at home, you're a microbiologist.' says Dr. Charles Bamforth ...

Genetics Society of America's Genetics journal highlights for February 2013

2013-02-08
Bethesda, MD—February 8, 2013 – Listed below are the selected highlights for the February 2013 issue of the Genetics Society of America's journal, Genetics. The February issue is available online at www.genetics.org/content/current. Please credit Genetics, Vol. 193, February 2013, Copyright © 2013. Please feel free to forward to colleagues who may be interested in these articles on population and evolutionary genetics; gene expression; genome and systems biology; and methods, technology and resources. ISSUE HIGHLIGHTS Population and Evolutionary Genetics Patterns ...

Combining plasma screening methods better identifies diagnostic and therapeutic targets

2013-02-08
BETHESDA, MD — February 8, 2013 — For the first time, scientists have combined genomic and proteomic analysis of blood plasma to enhance identification of genetically regulated protein traits. This could be applied to any large association study of civilization diseases where blood plasma has been collected, vastly improving a clinician's ability to identify disease susceptibility in individuals and populations. This advance is published in the February 2013 issue of the journal Genetics. "We hope that combining genome-wide with proteome-wide screening of blood plasma ...

Putting our heads together: Canines may hold clues to human skull development

2013-02-08
BETHESDA, MD – February 8, 2013 -- Man's best friend may touch our hearts with their empathy, companionship, playfulness and loyalty, and they may also lead us to a deeper understanding of our heads. In the article, "The Genetics of Canine Skull Shape Variation," in the February issue of the Genetics Society of America's journal, Genetics, Jeffrey J. Schoenebeck, PhD, and Elaine A. Ostrander, PhD, researchers at the National Human Genome Research Institute (NHGRI), the National Institutes of Health (NIH), review progress in defining the genes and pathways that determine ...

LAST 30 PRESS RELEASES:

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

Mission accomplished for the “T2T” Hong Kong Bauhinia Genome Project

[Press-News.org] Researchers explore quantum entanglement
Paper in Physical Review Letters delves into phenomenon Einstein called 'spooky'